Literature DB >> 34564705

Myelopathy in sickle cell disease: a case-oriented review.

Igor Vilela Brum1, Guilherme Diogo Silva2, Diego Sant'Ana Sodre2, Felipe Melo Nogueira3, Samira Luisa Dos Apostolos Pereira2, Luiz Henrique Martins Castro2.   

Abstract

INTRODUCTION: Although neurological complications are well recognized in patients with sickle cell disease, myelopathy has been rarely described, with few reported cases of compressive and ischemic myelopathy. We present the first case report of longitudinally extensive myelitis (LETM) in SCD and review the differential diagnosis of myelopathy in these patients. CASE
PRESENTATION: We report the case of a 29-year-old African-Brazilian man with SCD, who experienced a subacute flaccid paraparesis, with T2 sensory level and urinary retention. Cerebrospinal fluid analysis showed a lymphocytic pleocytosis and increased protein levels. MRI disclosed a longitudinally extensive spinal cord lesion, with a high T2/STIR signal extending from C2 to T12. We searched Medline/PubMed, Embase, Scopus, and Google Scholar databases for myelopathy in SCD patients. DISCUSSION: Spinal cord compression by vertebral fractures, extramedullary hematopoietic tissue, and Salmonella epidural abscess have been reported in SCD. We found only three case reports of spinal cord infarction, which is unexpectedly infrequent compared to the prevalence of cerebral infarction in SCD. We found only one case report of varicella-zoster myelitis and no previous report of LETM in SCD patients. Specific and time-sensitive causes of myelopathy should be considered in SCD patients. In addition to compression and ischemia, LETM is a possible mechanism of spinal cord involvement in SCD patients.
© 2021. The Author(s), under exclusive licence to International Spinal Cord Society.

Entities:  

Mesh:

Year:  2021        PMID: 34564705      PMCID: PMC8464596          DOI: 10.1038/s41394-021-00449-8

Source DB:  PubMed          Journal:  Spinal Cord Ser Cases        ISSN: 2058-6124


  22 in total

1.  CT and MRI of symptomatic spinal involvement by extramedullary haemopoiesis.

Authors:  C Papavasiliou; A Gouliamos; L Vlahos; S Trakadas; A Kalovidouris; G Pouliades
Journal:  Clin Radiol       Date:  1990-08       Impact factor: 2.350

2.  Spinal cord infarction associated with the sickle cell trait.

Authors:  L Wolman; A G Hardy
Journal:  Paraplegia       Date:  1970-02

Review 3.  Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica.

Authors:  Corinna Trebst; Peter Raab; Elke Verena Voss; Paulus Rommer; Mazen Abu-Mugheisib; Uwe K Zettl; Martin Stangel
Journal:  Nat Rev Neurol       Date:  2011-11-01       Impact factor: 42.937

Review 4.  Neurologic Complications of Sickle Cell Disease.

Authors:  Shama Farooq; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-28       Impact factor: 5.081

5.  Acute spinal-cord ischemia: evolution of MRI findings.

Authors:  Cornelis L Alblas; Willem H Bouvy; Geert J Lycklama À Nijeholt; Jelis Boiten
Journal:  J Clin Neurol       Date:  2012-09-27       Impact factor: 3.077

6.  Spinal cord infarction in a patient with sickle cell anemia.

Authors:  S M Rothman; J S Nelson
Journal:  Neurology       Date:  1980-10       Impact factor: 9.910

7.  Sickle cell anemia and epidural extramedullary hematopoiesis.

Authors:  L M Lewkow; I Shah
Journal:  Am J Med       Date:  1984-04       Impact factor: 4.965

Review 8.  Spinal cord compression in beta-thalassemia: case report and review of the literature.

Authors:  S A Salehi; T Koski; S L Ondra
Journal:  Spinal Cord       Date:  2004-02       Impact factor: 2.772

9.  Inflammation in sickle cell disease.

Authors:  Nicola Conran; John D Belcher
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

10.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.